8-K - BioXcel Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Management Change

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On February 4

Management Change

$225.0K$650.0K$150.0K$325.0K

9.01

Financial Statements and Exhibits. (d) Exhibits. Ex. No. Description 10.1 Form of Milestone and Retention Bonus Agreement, dated February 4, 2026 by and between

Exhibits Only

Exhibits (2)

10.1

EXHIBIT 10.1

8-K

FORM 8-K